KMI
59
2
XYL
54
-4
HIG
68
4
DAL
62
-4
ADP
69
-3
TRV
64
2
EIX
69
3
NKE
46
12
SYF
65
-6
NAVI
55
-2
IP
39
-6
PEP
47
-3
FIS
46
-4
URI
58
-5
MDLZ
65
-2
PEG
76
5
GOOG
67
2
AVB
65
-2
MAS
67
-3
RRC
56
4
KMI
59
2
XYL
54
-4
HIG
68
4
DAL
62
-4
ADP
69
-3
TRV
64
2
EIX
69
3
NKE
46
12
SYF
65
-6
NAVI
55
-2
IP
39
-6
PEP
47
-3
FIS
46
-4
URI
58
-5
MDLZ
65
-2
PEG
76
5
GOOG
67
2
AVB
65
-2
MAS
67
-3
RRC
56
4
Financhill
Back

Biomarin Pharmaceutical Vs. Alnylam Pharmaceuticals Industry Stock Comparison

Sell
35

BMRN
Biomarin Pharmaceutical

Last Price:
70.70
Seasonality Move:
5.7%
Sell
40

ALNY
Alnylam Pharmaceuticals

Last Price:
273.83
Seasonality Move:
3.21%
Sell
35
Biomarin Pharmaceutical (BMRN) is a Sell

Is Biomarin Pharmaceutical a Buy, Sell or Hold?

  • The current Biomarin Pharmaceutical [BMRN] share price is $70.69. The Score for BMRN is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • BMRN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
Alnylam Pharmaceuticals (ALNY) is a Sell

Is Alnylam Pharmaceuticals a Buy, Sell or Hold?

  • The current Alnylam Pharmaceuticals [ALNY] share price is $273.88. The Score for ALNY is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • ALNY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BMRN Stock Price Chart

What is Biomarin Pharmaceutical's stock price today?

  • The Biomarin Pharmaceutical share price today is $70.69
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing slight selling pressure.

ALNY Stock Price Chart

What is Alnylam Pharmaceuticals's stock price today?

  • The Alnylam Pharmaceuticals share price today is $273.88
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing slight buying pressure.

BMRN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -4.4 Sell
Relative Strength Index (14 RSI): 22.78 Sell
Chaikin Money Flow: -1009919 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (77.4 - 92.98) Sell
Bollinger Bands (100): (78.06 - 88.38) Sell

ALNY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.42 Buy
Relative Strength Index (14 RSI): 58.09 Buy
Chaikin Money Flow: 377648 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (257.34 - 278.94) Buy
Bollinger Bands (100): (166.06 - 270.8) Buy

BMRN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 75.96 Sell
20-day SMA: 83.55 Sell
50-day SMA: 85.45 Sell
200-day SMA: 86.8 Sell
8-day EMA: 75.07 Sell
20-day EMA: 80.72 Sell
50-day EMA: 83.8 Sell
200-day EMA: 85.86 Sell

ALNY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 269.63 Buy
20-day SMA: 266.18 Buy
50-day SMA: 260.04 Buy
200-day SMA: 192.17 Buy
8-day EMA: 270.19 Buy
20-day EMA: 266.62 Buy
50-day EMA: 254.32 Buy
200-day EMA: 208.68 Buy

Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.31 per share, an increase next quarter of $0.29 per share, an increase this year of $1.19 per share, and an increase next year of $1.04 per share.

Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.57 per share, an increase next quarter of $0.47 per share, an increase this year of $1.30 per share, and an increase next year of $0.57 per share.

Biomarin Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Alnylam Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):